155 related articles for article (PubMed ID: 10559661)
1. Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis.
Kitawaki J; Kusuki I; Koshiba H; Tsukamoto K; Honjo H
Gynecol Obstet Invest; 1999; 48 Suppl 1():21-8. PubMed ID: 10559661
[TBL] [Abstract][Full Text] [Related]
2. Aromatase expression in endometriosis.
Noble LS; Simpson ER; Johns A; Bulun SE
J Clin Endocrinol Metab; 1996 Jan; 81(1):174-9. PubMed ID: 8550748
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element.
Zeitoun K; Takayama K; Michael MD; Bulun SE
Mol Endocrinol; 1999 Feb; 13(2):239-53. PubMed ID: 9973254
[TBL] [Abstract][Full Text] [Related]
4. Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis.
Kitawaki J; Kusuki I; Koshiba H; Tsukamoto K; Fushiki S; Honjo H
Fertil Steril; 1999 Dec; 72(6):1100-6. PubMed ID: 10593388
[TBL] [Abstract][Full Text] [Related]
5. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium.
Kitawaki J; Noguchi T; Amatsu T; Maeda K; Tsukamoto K; Yamamoto T; Fushiki S; Osawa Y; Honjo H
Biol Reprod; 1997 Sep; 57(3):514-9. PubMed ID: 9282984
[TBL] [Abstract][Full Text] [Related]
6. WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells.
Gurates B; Sebastian S; Yang S; Zhou J; Tamura M; Fang Z; Suzuki T; Sasano H; Bulun SE
J Clin Endocrinol Metab; 2002 Sep; 87(9):4369-77. PubMed ID: 12213901
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
[TBL] [Abstract][Full Text] [Related]
9. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
10. [P450Arom and estrogenic microenvironment of eutopic endometria in endometriosis].
Johnson MC; Pinto C; Alves A; Palomino A; Fuentes A; Boric MA; Vega M
Rev Med Chil; 2004 Dec; 132(12):1475-82. PubMed ID: 15743158
[TBL] [Abstract][Full Text] [Related]
11. [Semiquantitative analysis of mRNA aromatase expression in eutopic endometrium as a diagnostic marker of endometriosis and estrogen dependent diseases].
Visnovský J; Galo S; Zúbor P; Hatok J; Racay P; Danko J
Ceska Gynekol; 2008 Jul; 73(4):213-7. PubMed ID: 18711959
[TBL] [Abstract][Full Text] [Related]
12. Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis.
Dheenadayalu K; Mak I; Gordts S; Campo R; Higham J; Puttemans P; White J; Christian M; Fusi L; Brosens J
Fertil Steril; 2002 Oct; 78(4):825-9. PubMed ID: 12372463
[TBL] [Abstract][Full Text] [Related]
13. Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis.
Hudelist G; Czerwenka K; Keckstein J; Haas C; Fink-Retter A; Gschwantler-Kaulich D; Kubista E; Singer CF
Reprod Sci; 2007 Dec; 14(8):798-805. PubMed ID: 18089598
[TBL] [Abstract][Full Text] [Related]
14. Progesterone induction of 17beta-hydroxysteroid dehydrogenase type 2 during the secretory phase occurs in the endometrium of estrogen-dependent benign diseases but not in normal endometrium.
Kitawaki J; Koshiba H; Ishihara H; Kusuki I; Tsukamoto K; Honjo H
J Clin Endocrinol Metab; 2000 Sep; 85(9):3292-6. PubMed ID: 10999824
[TBL] [Abstract][Full Text] [Related]
15. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of the detection of aromatase cytochrome P450 and CA125 for endometriosis].
Zeng F; Xue M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):682-5. PubMed ID: 16708809
[TBL] [Abstract][Full Text] [Related]
17. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection.
Matsuzaki S; Canis M; Pouly JL; Déchelotte PJ; Mage G
Fertil Steril; 2006 Feb; 85(2):308-13. PubMed ID: 16595205
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis: the pathophysiology as an estrogen-dependent disease.
Kitawaki J; Kado N; Ishihara H; Koshiba H; Kitaoka Y; Honjo H
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):149-55. PubMed ID: 12650711
[TBL] [Abstract][Full Text] [Related]
19. c-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action.
Morsch DM; Carneiro MM; Lecke SB; Araújo FC; Camargos AF; Reis FM; Spritzer PM
J Mol Histol; 2009 Feb; 40(1):53-8. PubMed ID: 19199093
[TBL] [Abstract][Full Text] [Related]
20. Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis.
Hatok J; Zubor P; Galo S; Kirschnerova R; Dobrota D; Danko J; Racay P
Gynecol Endocrinol; 2011 May; 27(5):331-6. PubMed ID: 20553220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
